Skip to content
Disclosery

EXANE DERIVATIVES: GOOGL position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on GOOGL, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 2,245 GOOGL shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 2,245 shares
    Change vs previous 13F -323 shares

    2.81% of the 13F portfolio, value $4,891,360.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,568 shares
    Change vs previous 13F -220 shares

    2.01% of the 13F portfolio, value $7,141,969.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,788 shares
    Change vs previous 13F -225 shares

    1.96% of the 13F portfolio, value $8,076,544.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 3,013 shares
    Change vs previous 13F +131 shares

    2.01% of the 13F portfolio, value $8,054,916.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 2,882 shares
    Change vs previous 13F +504 shares

    1.72% of the 13F portfolio, value $7,339,736.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 2,378 shares
    Change vs previous 13F -374 shares

    1.48% of the 13F portfolio, value $4,904,375.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 2,752 shares
    Change vs previous 13F -133 shares

    1.46% of the 13F portfolio, value $4,822,963.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 2,885 shares
    Change vs previous 13F not available

    1.38% of the 13F portfolio, value $4,228,080.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).